![Jason Coloma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Coloma
Directeur Général chez
Maze Therapeutics, Inc.
Fortune : 7 M $ au 31/07/2026
Profil
Jason V.
Coloma is currently Chief Executive Officer & Director at Maze Therapeutics, Inc., Director at St. Anthony's Foundation, and Director at Braveheart Bio, Inc. since 2024.
Former roles include Independent Director at BioAge Labs, Inc. from 2021 to 2024, Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc., and VP & Global Head-Roche Oncology Business at Roche Diagnostics Corp.
from 2008 to 2016.
Education includes a doctorate from the University of California, Berkeley, an undergraduate degree from the University of San Francisco, and an MBA from the Tuck School of Business at Dartmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases 0,5% | 03/08/2026 | 276 007 ( 0,5% ) | 7 M $ | 31/07/2026 |
1,27% | 06/08/2026 | 1 100 456 ( 1,27% ) | 11 $ | 31/07/2026 |
Postes actifs de Jason Coloma
| Sociétés | Poste | Début |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Directeur Général | 01/07/2019 |
St. Anthony's Foundation
 St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Directeur/Membre du Conseil | - |
Anciens postes connus de Jason Coloma
| Sociétés | Poste | Fin |
|---|---|---|
| BIOAGE LABS, INC. | Directeur/Membre du Conseil | 20/08/2024 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | 01/01/2016 |
| CORVUS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Jason Coloma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Anthony's Foundation
St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
